Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 139 recruiting studies, sorted by proximity — each links to its official registry page
A Study of ZL-1310 in Participants With Selected Solid Tumors
Solid Tumors
Phase 1, Phase 2
Interventional 166 participants sought
Texas Oncology - Central South — McAllen, Texas (1.8 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Texas Valley Clinical Research - Mission, TX — Mission, Texas (4.9 mi)
· Sponsor: Sparrow Pharmaceuticals
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
HCA Research Institute — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Pharr, Texas (4.4 mi)
· Sponsor: Akero Therapeutics, Inc
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Ventricular Ejection Fraction, LVF
N/A
Observational 2,000 participants sought
South Heart Clinic — Weslaco, Texas (16.5 mi)
· Sponsor: Peerbridge Health, Inc
A Randomized Control Trial of Conversations Advancing Resilience and Empowerment (CARE) Intervention
Quality of Life, Health Promotion
N/A
Interventional 200 participants sought
The University of Texas at Rio Grande Valley — Edinburg, Texas (7.4 mi)
· Sponsor: University of Texas Rio Grande Valley
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: Mercy Health Ohio
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Dr. Ruben Aleman and Associates — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Biopharma Informatic-McAllen — McAllen, Texas (1.8 mi)
· Sponsor: Amgen
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Boehringer Ingelheim
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Great Lakes Research Institute — Pharr, Texas (4.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Texas Oncology - McAllen — McAllen, Texas (1.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD
Dry Age-related Macular Degeneration
Phase 3
Interventional 237 participants sought
Valley Retina Institute — McAllen, Texas (1.8 mi)
· Sponsor: Ocugen
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Langerhans Cell Histiocytosis
Phase 3
Interventional 124 participants sought
Vannie Cook Children's Clinic — McAllen, Texas (1.8 mi)
· Sponsor: Baylor College of Medicine
Multi-analyte Blood Test Clinical Trial
Liver Cirrhosis, Liver Cancer
N/A
Observational 1,200 participants sought
South Texas Research Institute — Edinburg, Texas (7.4 mi)
· Sponsor: Helio Genomics
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Texas Valley Clinical Research (TVCR) - Mission — Mission, Texas (4.9 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — McAllen, Texas (1.8 mi)
· Sponsor: AstraZeneca
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — McAllen, Texas (1.8 mi)
· Sponsor: Dogwood Therapeutics Inc.
FebriDx® Pediatric Validation Study
Acute Respiratory Infections (ARIs)
N/A
Observational 800 participants sought
PAS Research — Edinburg, Texas (7.4 mi)
· Sponsor: Lumos Diagnostics
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Vannie Cook Children's Clinic — McAllen, Texas (1.8 mi)
· Sponsor: Children's Oncology Group
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Weslaco, Texas (16.5 mi)
· Sponsor: AstraZeneca
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: SWOG Cancer Research Network